Document Detail


Pharmacokinetics of tolfenamic acid and its detection time in urine after intravenous administration of the drug in camels (Camelus dromedarius).
MedLine Citation:
PMID:  9829406     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To document tolfenamic acid disposition variables, identify its major phase-1 metabolite and fragmentation pattern, and establish detection time in urine after single IV bolus administration to make recommendations on avoiding violative residues in racing camels. ANIMALS: 7 healthy camels (6 males, 1 female), 8 to 11 years old and weighing from 300 to 480 kg. PROCEDURE: Blood samples were collected at 0, 5, 10, 15, 30, 45, and 60 minutes and at 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 12, 13, 14, 15, and 16 hours after IV administration of tolfenamic acid (2.0 mg/kg of body weight). Urine samples were collected daily for 14 days after drug administration. Serum tolfenamic acid concentration was measured; limit of quantification was 50 ng/ml. A metabolite of tolfenamic acid in urine was isolated and identified, and its major fragmentation pattern was verified. Screening for tolfenamic acid and its metabolite in urine was performed. RESULTS: Mean +/- SEM tolfenamic acid elimination half-life was 5.76+/-0.26 hours. Total body clearance was 0.109+/-0.011 L/kg/h, and steady-state volume of distribution was 0.68+/-0.06 L/kg. Detection time for tolfenamic acid and its hydroxylated metabolite in urine after IV administration of a dose of 2.0 mg/kg was 5 and 7 days, respectively. CONCLUSIONS: Camels eliminate tolfenamic acid mainly via metabolism more slowly than do cattle. The extrapolated dose regimen from cattle to camels appears inappropriate. Veterinarians are advised not to use tolfenamic acid in camels for at least 8 days prior to racing.
Authors:
I A Wasfi; M ElGhazali; A A Hadi; O Zorob; N S Boni; N A Alkatheeri; I M Barezaiq
Related Documents :
2387506 - Quantitative relation between gastric acid secretion and changes in urinary acid excret...
9572026 - Characterization of an isolate belonging to the newly described species mycobacterium h...
7066236 - Tlc separation of hippuric, mandelic, and phenylglyoxylic acids from urine after mixed ...
12351156 - Metabolites of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (phip) in human urine af...
10552486 - Accuracy of klason lignin and acid detergent lignin methods as assessed by bomb calorim...
18263716 - The intestine as source of cytotoxic mediators in shock: free fatty acids and degradati...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of veterinary research     Volume:  59     ISSN:  0002-9645     ISO Abbreviation:  Am. J. Vet. Res.     Publication Date:  1998 Nov 
Date Detail:
Created Date:  1999-01-25     Completed Date:  1999-01-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375011     Medline TA:  Am J Vet Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1451-8     Citation Subset:  IM    
Affiliation:
Camelracing Forensic Laboratory, Forensic Science Laboratory, Abu Dhabi, United Arab Emirates.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anthranilic Acids / administration & dosage,  pharmacokinetics*,  urine
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage,  pharmacokinetics*,  urine
Camels / metabolism*
Chromatography, High Pressure Liquid / veterinary
Chromatography, Thin Layer / veterinary
Drug Evaluation / veterinary
Female
Half-Life
Injections, Intravenous / veterinary
Male
Mass Spectrometry / veterinary
Metabolic Clearance Rate
Models, Chemical
Chemical
Reg. No./Substance:
0/Anthranilic Acids; 0/Anti-Inflammatory Agents, Non-Steroidal; 13710-19-5/tolfenamic acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacokinetics of multiple-dose administration of eltenac in horses.
Next Document:  Normal variation in, and effect of 2% pilocarpine on, intraocular pressure and pupil size in female ...